Articles On Capitol Health (ASX:CAJ)

An additional news report on the recommendation, valuation, forecast and opinion changes for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Au...

By Tim Boreham, Editor, The New Criterion The overlooked small cap champions defying the coronavirus gloom. As the now-concluded earnings reporting season shows, the pandemic has created a distinct market of winners and losers – intersperse...

As the now-concluded earnings reporting season shows, the COVID-19 pandemic has created a distinct market of winners and losers – interspersed with a few plodders just getting by. The trouble with the obvious COVID-19 beneficiaries such as...

ShareCafeOvernight: Onward Ever Upward World Overnight SPI Overnight (Sep) 5950.00 + 23.00 0.39% S&P ASX 200 5953.40 – 107.10 – 1.77% S&P500 3526.65 + 26.34 0.75% Nasdaq Comp 11939.67 + 164.21 1.39% DJIA 28645.66 + 215.6...

World Overnight SPI Overnight (Sep) 5950.00 + 23.00 0.39% S&P ASX 200 5953.40 – 107.10 – 1.77% S&P500 3526.65 + 26.34 0.75% Nasdaq Comp 11939.67 + 164.21 1.39% DJIA 28645.66 + 215.61 0.76% S&P500 VIX 26.12 – 0.29 –...

ShareCafeOvernight: Back To The Eighties World Overnight SPI Overnight (Sep) 5972.00 – 58.00 – 0.96% S&P ASX 200 6060.50 – 13.30 – 0.22% S&P500 3500.31 – 7.70 – 0.22% Nasdaq Comp 11775.46 + 79.82 0.68% DJIA 28430.05 – 22...

World Overnight SPI Overnight (Sep) 5972.00 – 58.00 – 0.96% S&P ASX 200 6060.50 – 13.30 – 0.22% S&P500 3500.31 – 7.70 – 0.22% Nasdaq Comp 11775.46 + 79.82 0.68% DJIA 28430.05 – 223.82 – 0.78% S&P500 VIX 26.41 + 3.4...

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((APT)) - Afterpay ((AGI)) - Ainsworth Game Techn ((AIZ)) - Air New Zealand ((APX)) - Appen ((ALX)) - Atlas Arteria ((CAJ)) - Capitol Health ((CVN)) - Carnarvon Petroleum...

The market jumped to a three-month high on a quicker than expected recovery from the COVID-19 pandemic. The S&P/ASX 200 Index (Index:^AXJO) jumped 2.4% to 6,145 points as we head into the close as a sense of FOMO gripped the market. I...

Participating in small cap raises is proving lucrative for investors, with shares in 47 small caps that tapped equity markets in April currently trading higher than the price at which they raised cash. Stockhead counted at least 66 offers i...

Over the last couple of weeks I, Claude here, have been buying tiny positions in a wide range of companies in the hope that these holdings will give me the right to buy shares at a discounted (and attractive) price. Here are three shares th...

Shaw and Partners was pleased to be appointed as Lead Manager to an equity capital raising by Capitol Health (ASX: CAJ).   Capitol Health successfully raised up to $29.8 ... Read More

Capitol Health will go to investors seeking a $40 million equity top up on Tuesday. 

Here it is – your weekly look at the stocks fund managers are buying (and selling). Trading Places is Stockhead’s recap of substantial holder movements among ASX small caps in the last week. Substantial shareholders are shareholders holding...

An additional news report on the recommendation, valuation, forecast and opinion changes for ASX-listedequities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArenahas now added The Aust...

The market carnage is certainly proving a great buying opportunity for directors, with even more last week, compared to the week before, scrambling to top up their holdings. Stockhead found 19 directors trades over $100,000 among ASX small...

Diagnostic imaging services provider Capitol Health (ASX:CAJ) will drop a cool $16m to pick up what it calls “South Australia’s leading musculoskeletal imaging centre”. As part of its plans to expand into Adelaide, Capitol is buying Fowler...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

In the health care industry, there is usually an urgent requirement to find innovative ways to improve a patient’s health condition because of the rise in aging population and increasing chronic diseases across the world. Introduction of di...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

Introduction Its seen that in September 2019, NAOS Small Cap Opportunities Company Ltd performed better than Naos Emerging Opportunities Company Ltd. This also reflects the better performance of small cap compared to micro-cap. In September...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

How to Find Value Stocks on ASX Value Stock: Value stock is a stock that has a good future prospect of growth and trades at a lower price relative to its fundamentals. It is most likely to come from a mature company with stable dividends bu...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

An additional news report on the recommendation, valuation, forecast and opinion changes for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The...

In this week’s recap of substantial holder movements four substantial holders bought shares in Zenith Energy (ASX:ZEN), a Shanghai investor bought into Anson Resources (ASX:ASN) and Sirtex’s founder bought into Syrah Resources (ASX:SYR). Su...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

As the financial year winds down, we have reported small caps making money in a wide variety of ways. This has ranged from selling almonds to selling used cars or even cleaning up after floods and hail storms. Today, Queensland infrastructu...

In this week’s recap of substantial holders, a Dubai executive bought into Prospect Resources (ASX: PSC), Salt Funds Management sold $8.3 million of Monash IVF (ASX: MVF) and a tin company raised $20 million to save itself from the ‘three-y...